As indicated in the previous section on quantification of premature mortality benefits, we assume for this analysis that some of the incidences of premature mortality related to PM exposures occur in a distributed fashion over the five years following exposure.
For the purposes of this analysis, we think that there will be no cases of premature mortality within five years of PM exposure.